Cite
HARVARD Citation
Rosu, L. et al. (2023). Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomised controlled trial. Lancet. 11 (2), pp. e265-e277. [Online].